Clinical Trials Browser

Multiple Myeloma, Renal Insufficiency

NCT06623630 2026-03-11

Lymphodepleting Total Body Irradiation (TBI) Plus Cyclophosphamide Prior to Ciltacabtagene Autoleucel (Carvykti; Cilta-cel) for Multiple Myeloma (MM) Patients With Impaired Renal Function

Phase 1 Recruiting

16 enrolled

Plasma cell

Multiple Myeloma, Renal Insufficiency

NCT06004661 2026-03-06

Study of Lutetium (177Lu) Vipivotide Tetraxetan in mCRPC Participants With Moderately and Severely Impaired and With Normal Renal Function

Phase 2 Recruiting

20 enrolled

Renal Insufficiency

NCT07029503 2026-02-24

SCARF-1

Phase 2 Recruiting

40 enrolled

Lymphoid

Heart Failure, Lymphoma, Follicular, Renal Insufficiency, Chronic, Renal Insufficiency

NCT04240054 2026-01-28

VICD

Phase 2 Recruiting

41 enrolled

Plasma cell

Multiple Myeloma, Renal Insufficiency

NCT05992363 2025-07-24

TSTENT

Phase NA Recruiting

106 enrolled

Bites and Stings, Hydronephrosis, Neoplasms, Ureteral Obstruction, Renal Insufficiency

NCT07053462 2025-07-08

CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk

Phase 1/2 Recruiting

90 enrolled

Genitourinary

Carcinoma, Renal Cell, Kidney Failure, Chronic, Renal Insufficiency

NCT03101995 2025-05-28

Assessment of Gemcitabine as Chemoradiotherapy in Patients With Locally Advanced Carcinoma of Cervix and Renal Disease

Phase 2 Recruiting

18 enrolled

Gynecologic

Uterine Cervical Neoplasms, Renal Insufficiency

NCT06337942 2025-02-12

Deceased Donor Bladder or Combined Kidney-bladder Transplantation: a Phase 0 First-in-human Study

Phase NA Recruiting

5 enrolled

Genitourinary

Urinary Bladder Diseases, Urinary Bladder Neoplasms, Urinary Bladder, Neurogenic, Renal Insufficiency

Clinical Trials

Pilot Study Dara-CyBorD in Newly Diagnosed Multiple Myeloma Patients With Renal Failure

Lymphodepleting Total Body Irradiation (TBI) Plus Cyclophosphamide Prior to Ciltacabtagene Autoleucel (Carvykti; Cilta-cel) for Multiple Myeloma (MM) Patients With Impaired Renal Function

Study of Lutetium (177Lu) Vipivotide Tetraxetan in mCRPC Participants With Moderately and Severely Impaired and With Normal Renal Function

SCARF-1

VICD

TSTENT

CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk

Assessment of Gemcitabine as Chemoradiotherapy in Patients With Locally Advanced Carcinoma of Cervix and Renal Disease

Deceased Donor Bladder or Combined Kidney-bladder Transplantation: a Phase 0 First-in-human Study